Singapore markets closed

Straits Times Index
3,297.55
-26.98(-0.81%)
Nikkei
38,814.56
+94.09(+0.24%)
Hang Seng
17,941.78
-170.85(-0.94%)
FTSE 100
8,146.86
-16.81(-0.21%)
Bitcoin USD
66,592.98
+299.84(+0.45%)
CMC Crypto 200
1,379.68
-38.19(-2.69%)

EW Aug 2024 97.500 call

OPR - OPR Delayed price. Currency in USD

Add to watchlist

1.3000

0.0000

(0.00%)

As of 02:23PM EDT. Market open.

Loading interactive chart…

Zacks
HOLX vs. EW: Which Stock Should Value Investors Buy Now?
HOLX vs. EW: Which Stock Is the Better Value Option?
Zacks
BD (BDX) Inks Buyout Deal to Expand Smart Connected Care Suite
BD's (BDX) latest agreement is likely to unlock new future value-creation opportunities and expand its portfolio of smart connected care solutions.
Business Wire
Five-Year Data Show Excellent Outcomes for Female and Small Annulus Patients With Edwards TAVR
NEW YORK, June 05, 2024--Edwards Lifesciences (NYSE: EW) today announced the results from an analysis of data from the PARTNER Trials examining outcomes of transcatheter aortic valve replacement (TAVR) patients with a small annulus. Through five-year follow up of more than 1,300 low and intermediate risk SAPIEN 3 valve patients there were excellent clinical outcomes and valve durability irrespective of the patient’s annulus size or sex. These data were presented during the late-breaking clinical